Lindbrook Capital’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $2.54K | Hold |
8,920
| – | – | ﹤0.01% | 2212 |
|
|
2024
Q4 | $5.23K | Hold |
8,920
| – | – | ﹤0.01% | 1965 |
|
|
2024
Q3 | $3.98K | Sell |
8,920
-3,818
| -30% | -$1.7K | ﹤0.01% | 2106 |
|
|
2024
Q2 | $33.8K | Hold |
12,738
| – | – | ﹤0.01% | 968 |
|
|
2024
Q1 | $34.9K | Buy |
12,738
+3,000
| +31% | +$8.22K | ﹤0.01% | 935 |
|
|
2023
Q4 | $23.7K | Hold |
9,738
| – | – | ﹤0.01% | 1091 |
|
|
2023
Q3 | $19.7K | Sell |
9,738
-1,669
| -15% | -$3.37K | ﹤0.01% | 1067 |
|
|
2023
Q2 | $33.7K | Hold |
11,407
| – | – | ﹤0.01% | 850 |
|
|
2023
Q1 | $28.5K | Hold |
11,407
| – | – | ﹤0.01% | 917 |
|
|
2022
Q4 | $36.2K | Sell |
11,407
-5,513
| -33% | -$17.5K | ﹤0.01% | 814 |
|
|
2022
Q3 | $50K | Sell |
16,920
-6,500
| -28% | -$19.2K | 0.01% | 640 |
|
|
2022
Q2 | $71K | Sell |
23,420
-753
| -3% | -$2.28K | 0.01% | 539 |
|
|
2022
Q1 | $326K | Buy |
24,173
+953
| +4% | +$12.9K | 0.05% | 214 |
|
|
2021
Q4 | $303K | Buy |
23,220
+8,189
| +54% | +$107K | 0.05% | 229 |
|
|
2021
Q3 | $141K | Sell |
15,031
-25,108
| -63% | -$236K | 0.04% | 213 |
|
|
2021
Q2 | $411K | Buy |
40,139
+15,212
| +61% | +$156K | 0.09% | 91 |
|
|
2021
Q1 | $459K | Sell |
24,927
-2,100
| -8% | -$38.7K | 0.1% | 76 |
|
|
2020
Q4 | $926K | Buy |
27,027
+11,452
| +74% | +$392K | 0.23% | 39 |
|
|
2020
Q3 | $288K | Buy |
+15,575
| New | +$288K | 0.08% | 98 |
|